戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              STS analysis of nonlesional skin of AD children identifi
2                                              STS and 17beta-HSD1 are attractive targets for the treat
3                                              STS measures demonstrated poor repeatability, but the av
4                                              STS programs that voluntarily participate in public repo
5                                              STS proteomic analysis results were validated in an inde
6                                              STS public reporting participation varied from 22.2% to
7                                              STS public reporting sites had higher mean annualized co
8                                              STS results show the surface Fermi level remains unpinne
9                                              STS score tended to be lower in the new-generation devic
10                                              STS score, resting left ventricular ejection fraction, m
11                                              STS subtypes expressing elevated glutaminase (GLS) level
12                                              STS-E412 also increased phosphorylation of EPOR, CD131,
13                                              STS-E412 triggered EPO receptor phosphorylation in human
14                                             (STS/ACC Transcatheter Valve Therapy Registry [TVT Regist
15 illation (1.41; 95% CI, 1.06-1.87; P = .02), STS score (1.03; 95% CI, 1.01-1.06; P = .02), presence o
16 929 unique observations ( approximately 1000 STS participant centers, 9 reporting periods), 916 sites
17  commonly exceeded 25 miles: HCAHPS (39.2%), STS-CABG (62.7%), and US News Top Hospital (85.2%).
18 60.7 years +/- 19.2]); 72 of the 130 (55.4%) STSs were grade III.
19 .Hospitals were rated for HCAHPS (n = 4656), STS-CABG (n = 470), and US News Top Hospitals (n = 15).
20 emoral access (HR, 1.37; 95% CI, 1.27-1.48), STS PROM score greater than 15% vs less than 8% (HR, 1.8
21  exceeded 25 miles commonly: HCAHPS (23.7%), STS-CABG (36.7%), US News Top Hospitals (81.8%).Signific
22 they may explain why some patients develop a STS at the site of injury.
23 other first-line chemotherapies for advanced STS.
24                                  In advanced STS, PFS and RR seem to be appropriate surrogates for OS
25 orubicin as first-line treatment of advanced STS patients.
26 in alone as first-line treatment of advanced STS.
27 antation, 383 (202 TAVR and 181 SAVR) had an STS PROM of 7% or less (median [interquartile range]: TA
28 ho underwent an attempted implant and had an STS PROM of 7% or less.
29                  These results illuminate an STS network involved in processes associated with multip
30 e-in-ring procedures were high risk, with an STS PROM for mitral valve replacement of 11%.
31 iomyopathy Questionnaire in patients with an STS PROM score of 7% or less.
32                               TNF-alpha- and STS-induced acetylation of H3 and H4 histones was attenu
33       The LrS attenuated both TNF-alpha- and STS-induced gene expression involved in NF-kappaB and MA
34 LrS, as was the production of TNF-alpha- and STS-induced proinflammatory cytokines and chemokines.
35 functional connectivity between amygdala and STS.
36  with the Pentacam and BioGraph devices) and STS (measured with the HiScan device) were estimated.
37 rcinomas observed in 79% of the females, and STS observed in 27% of the patients.
38 e activation than naming in both SII/OP1 and STS bilaterally.
39 The tradeoff between activity in SII/OP1 and STS was not observed during reading, which showed signif
40  putative sCSCs, autologous bone sarcoma and STS cells were engineered with a CSC detector vector enc
41  generally stimulated, in line with UFGT and STS expression patterns.
42 ge interdevice bias was observed for WTW and STS measures.
43 th Si-H termination as confirmed by XPS, and STS results confirm the saturated Si-Hx bilayer leaves t
44 ies or objects) in the rpSTS, right anterior STS (raSTS), and right amygdala, compared with TBS deliv
45 ies or objects, in the rpSTS, right anterior STS (raSTS), and right amygdala.
46             As one of our examples, we apply STS to check nonclassical correlations among sites in a
47                          Using autochthonous STS murine models and unbiased metabolomics, we demonstr
48 t + wavelength lambda) DS dynamics imaged by STS compressed ultrafast photography, enabling imaging a
49 cic Surgeons/American College of Cardiology (STS/ACC) Transcatheter Valve Therapies Registry were lin
50 e movement types requires access to a common STS network and that individual network nodes are recrui
51 characterization of the nonpeptidyl compound STS-E412 (2-[2-(4-chlorophenoxy)ethoxy]-5,7-dimethyl-[1,
52             At low nanomolar concentrations, STS-E412 provided EPO-like cytoprotective effects in pri
53 hods: In total, 37 patients with a confirmed STS of the extremities underwent (18)F-FDG PET/MRI befor
54 apped with phloem enzymes along the cucurbit STS.
55  Space Transportation System (STS)-131, 13-d STS-135, and 30-d Bion-M1 missions.
56 r results also reveal an area in dorsomedial STS that is modulated almost exclusively by vergence mov
57  a vergence-specific area within dorsomedial STS.
58 ropriate for preoperative IGRT for extremity STS.
59 atients with primary nonmetastatic extremity STS were treated with limb-sparing surgery and adjuvant
60 f late toxicities in patients with extremity STS who were treated with preoperative IGRT and absence
61  (PC1) with the highest expression in AD FA+ STSs.
62                                    The first STS dimension reflected segregation between drought-tole
63 D) and TP53 (R167H) transgenes, allowing for STS modeling in a spatial and temporal manner.
64 AHPS hospital (89.6%), but less commonly for STS-CABG (62.9%).
65  There exists a characteristic frequency for STS power dissipation, CFSTS, defined as the frequency w
66 les of neoadjuvant chemotherapy with RHT for STS.
67 les of neoadjuvant chemotherapy plus RHT for STS.
68 biota transplantation (FMT) experiments from STS, LTS, or control donors, we were able to differentia
69                                    Mice from STS missions were euthanized within 4 h after landing, w
70 est convergent evolution of plant and fungal STSs, and also indicate that the colocalized PT-TPS gene
71 te of 50%, highlighting the need for further STS research.
72 features that are associated with high-grade STS (grade III) and to determine the relationship betwee
73  we show that HIF-2alpha inhibits high-grade STS cell growth in vivo, as loss of HIF-2alpha promotes
74  rating for coronary artery bypass grafting (STS-CABG), and Centers for Medicare and Medicaid Service
75 r rates of comorbidities leading to a higher STS predicted risk of mortality (median 13.5% vs. 6.2%;
76                            They had a higher STS risk score for mortality (4.8+/-1.7% vs 4.4+/-1.5%;
77  multivariable Cox survival analysis, higher STS score (hazard ratio [HR]: 1.14), more abnormal resti
78  women and had more comorbidities and higher STS mortality risk scores.
79 nst depressive symptoms, possibly via higher STS expression/activity (resulting in elevated endogenou
80 n the horizontal WTW measures and horizontal STS estimates when bias was accounted for was small ghe,
81  WTW measures were wider than the horizontal STS measures (bias >0.91 mm, P < .01).
82 a) RNA-seq data to compare Oncopig and human STS expression profiles.
83 l models representative of the diverse human STS subtypes critical.
84 e Oncopig STS model's ability to mimic human STS transcriptional profiles, providing a valuable resou
85                      We find that most human STS have lower levels of EPAS1 (the gene encoding HIF-2a
86           Transcriptional hallmarks of human STS were observed in Oncopig STS, including altered TP53
87 s previously identified as a potential human STS therapeutic target.
88 4 expression in established murine and human STSs decreased tumor volume by almost two-thirds and cel
89  MRI features were associated with grade III STS: peritumoral enhancement (odds ratio [OR], 3.4; P =
90 ses as early in the auditory hierarchy as in STS are more correlated with semantic than spectral repr
91 ha as a biomarker for Vorinostat efficacy in STS.
92 ral vocal features, which was not evident in STS units.
93 ystematic review of systemic therapy RCTs in STS was performed.
94 omas (STSs) to determine NG2/CSPG4's role in STS initiation and growth.
95 ulatory and semantic in STS, and semantic in STS and beyond.
96 TG, mixtures of articulatory and semantic in STS, and semantic in STS and beyond.
97  of this combination in vitro and in vivo in STS cell lines and in a patient-derived xenograft model.
98                      Many cancers, including STS, contain altered epigenetics, and our findings defin
99             Institutional STS data including STS predicted risk of postoperative stroke score were us
100          Drugs have been designed to inhibit STS, e.g., Irosustat, as innovative dual-targeting aroma
101 idating EO-33's in vivo potential to inhibit STS, to prevent bone deterioration, and to reduce estrog
102                          Vorinostat inhibits STS tumour growth, an effect ameliorated by HIF-2alpha d
103                                Institutional STS data including STS predicted risk of postoperative s
104                            To our knowledge, STS-E412 is the first nonpeptidyl, selective activator o
105                      In fungi, all six known STSs are bifunctional, containing C-terminal trans-preny
106 ity in the left superior temporal sulcus (L. STS), a key site for the integration of real audiovisual
107              These results suggest that left STS is more sensitive to happy speech as compared to ang
108                                         Mean STS score was 3.98 +/- 1%; 54% of patients were in New Y
109                                         Mean STS score was 5.5% +/- 8%, and mean LVEF was 57 +/- 4%,
110          A total of 331 patients with a mean STS score of 6.7 +/- 6.7 underwent TAVR.
111   The mean age was 79.1+/-4.8 years and mean STS-PROM score was 3.0%+/-1.7%.
112 iple comorbidities, reflected by a high mean STS predicted risk of mortality (STS PROM) for surgical
113 age of patients was 75.4 years, and the mean STS-PROM score was 2.3%.
114 istics (age, 79+/-8.2 years; 60% women; mean STS [Society of Thoracic Surgery] score 8.1+/-5.5%).
115                                       Median STS-PROM score 8.6%; median clinical follow-up 492 days
116 nd 739 (mean age 82.8 years [SD 4.1]; median STS-PROM score 3.5% [IQR 2.6-5.0]) were enrolled.
117 s 84 years and 52% were women, with a median STS Predicted Risk of Operative Mortality (STS PROM) sco
118 ly stratified patients by the overall median STS PROM score (7%) and analyzed clinical outcomes and q
119 tment for progressive advanced or metastatic STS who had Eastern Cooperative Oncology Group performan
120 evels <3.3 g/dl, falls in the past 6 months, STS PROM score >7%, and severe (>/=5) Charlson comorbidi
121 oracic Surgeons Predicted Risk of Mortality (STS PROM) alone is sufficient to define decreased risk,
122 a high mean STS predicted risk of mortality (STS PROM) for surgical valve replacement (8.34%), were h
123 oracic Surgeons Predicted Risk of Mortality (STS PROM) has trended downward in US TAVR trials and the
124 oracic Surgeons Predicted Risk of Mortality (STS PROM), and subjective criteria to assess patients' e
125 oracic Surgeons Predicted Risk of Mortality (STS-PROM) (<4% versus >/=4%), there was no statistically
126 oracic Surgeons Predicted Risk of Mortality (STS-PROM) category.
127 expected risk of 30-day operative mortality (STS Predicted Risk of Mortality [PROM]) of 7% to 6% and
128 n STS Predicted Risk of Operative Mortality (STS PROM) score of 7.1%.
129 oracic Surgeons Predicted Risk of Mortality [STS-PROM] score <4%) were included.
130 but not HIF-1alpha, accumulation in multiple STS subtypes.
131 o the generally assumed shear flow, nonshear STS flow patterns were simulated.
132 ver MRI data sets for response assessment of STS under neoadjuvant ILP.
133 y is an unusual but not rare complication of STS sclerotherapy.
134 umber of STS subtypes, making development of STS cell lines and animal models representative of the d
135  cohort validated differential expression of STS PC1 proteins in the skin of adult patients with AD w
136               The differential expression of STS PC1 proteins was confirmed in a replicate cohort of
137       We recently described a mouse model of STS whereby p53 is deleted and oncogenic Kras is activat
138 treatment planning and therapy monitoring of STS.
139 ll line availability and the large number of STS subtypes, making development of STS cell lines and a
140 ic disease, we showed that overexpression of STS in the liver of transgenic mice alleviated HFD and o
141       Further evaluation of the potential of STS-E412 in central nervous system diseases and organ pr
142      In defining the functional relevance of STS induction in metabolic disease, we showed that overe
143 ting the histopathologic therapy response of STS to neoadjuvant ILP.
144                  The receptor selectivity of STS-E412 was confirmed by a lack of phosphorylation of t
145                            This novel set of STS proteins was highly correlative to skin transepiderm
146                    The repeatability (Sr) of STS measured with the HiScan was 0.39 mm, which was sign
147 oring of neoadjuvant treatment strategies of STS.
148 peutic option in the first-line treatment of STS in patients age 60 years or older.
149         So far only a very limited number of STSs have been characterized.
150 60 and 7,652 genes was identified in Oncopig STS cell lines and leiomyosarcomas, respectively.
151 lmarks of human STS were observed in Oncopig STS, including altered TP53 signaling, Wnt signaling act
152    Furthermore, master regulators of Oncopig STS expression were identified, including FOSL1, which w
153        These results demonstrate the Oncopig STS model's ability to mimic human STS transcriptional p
154                  This study utilized Oncopig STS cell line (fibroblast) and tumor (leiomyosarcoma) RN
155                 Mutation of this site in one STS (AtTPS19) resulted in premature termination of carbo
156 pithelial cells challenged with TNF-alpha or STS.
157 nificant differences in preoperative risk or STS predicted risk of mortality between groups.
158 m those catalyzed by the characterized plant STSs by forming unified 15/5 bicyclic sesterterpene inte
159             The discovery of three new plant STSs is reported that produce a suite of sesterterpenes
160 ard medical therapy or standard therapy plus STS injection (80 mg, once daily for 14 consecutive days
161 ered over the face-selective right posterior STS (rpSTS) or over the vertex control site.
162                                 Preoperative STS predicted risk of postoperative stroke scores were n
163  compared with conventional EBRT for primary STS of the extremity.
164 er tissue injury in a mouse model of primary STS, and they may explain why some patients develop a ST
165 riptional responses to hypoxia, and promotes STS metastasis; however, the role of the related HIF-2al
166 of these as primary end points in randomized STS trials.
167                        AIF knockdown reduced STS-induced apoptosis in both of 16E6-expressing and 6E6
168             Patients had localized high-risk STS (grade 3; size, >= 5 cm) of an extremity or trunk wa
169 ulation of patients with localized high-risk STS, HT was not associated with a better DFS or OS, sugg
170 motherapy is used in patients with high-risk STS.
171  May 2015, 226 patients deemed extreme risk (STS-PROM [Society of Thoracic Surgeons Predicted Risk of
172 iteria in patients with soft-tissue sarcoma (STS) after combined chemotherapy plus regional hyperther
173 rolled trials (RCTs) in soft tissue sarcoma (STS) have used varying end points.
174     Background Managing soft-tissue sarcoma (STS) relies on histologic grade, which is the strongest
175      Some patients with soft-tissue sarcoma (STS) report a history of injury at the site of their tum
176 opathologic response of soft-tissue sarcoma (STS) to neoadjuvant isolated limb perfusion (ILP).
177 patients with extremity soft tissue sarcoma (STS) treated with preoperative image-guided radiation th
178 18 canine patients with soft tissue sarcoma (STS), CIVO captured complex, patient-specific tumor resp
179 sidered active drugs in soft tissue sarcoma (STS).
180 th advanced, inoperable soft tissue sarcoma (STS).
181                  Human soft-tissue sarcomas (STS) are rare mesenchymal tumors with a 5-year survival
182 (ACC), CNS tumors, and soft tissue sarcomas (STS) observed in 30%, 27%, 26%, and 23% of the patients,
183                     In soft tissue sarcomas (STS), low intratumoural O2 (hypoxia) is a poor prognosti
184 y of ATR inhibition in soft tissue sarcomas (STS).
185 (ILP) in patients with soft-tissue sarcomas (STS).
186                        Soft tissue sarcomas (STSs) are mesenchymal tumours where cytotoxic chemothera
187 thonous mouse model of soft-tissue sarcomas (STSs) to determine NG2/CSPG4's role in STS initiation an
188 {IQR}, 66-81 years]; 39.1%, women; mean [SD] STS-predicted risk of mortality, 4.9% [4.0%] and 5.1% [4
189 bsp. enterica serovar Typhimurium secretome (STS)-induced outcomes in human intestinal epithelial cel
190 f brain connectivity between voice-selective STS and reward, affective, salience, memory, and face-pr
191 the "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of P
192 dles are situated in the subtectorial space (STS)--a micrometer-thick space between two flat surfaces
193 defined a triangular stress tolerance space (STS).
194 carriers of 0.8-2.5 Mb duplications spanning STS, and non-carrier male (n = 192, 826) and female (n =
195                               Liver-specific STS induction or estrogen/estrogen sulfate delivery may
196 gly coupled across spatio-temporal-spectral (STS) domains.
197 ith CO-tip, scanning tunneling spectroscopy (STS), and density functional theory (DFT).
198 stigated by scanning tunneling spectroscopy (STS), in combination with DFT calculations, which reveal
199 ified using scanning tunneling spectroscopy (STS).
200 (EIS), and scanning tunnelling spectroscopy (STS).
201 es, the USDA Forest Service Slow the Spread (STS) programme for managing the future spread of gypsy m
202                           A supine-to-stand (STS) test was conducted to evaluate cardio-postural cont
203                 Under short-term starvation (STS, 3 h), both pheromone and opioid signaling were down
204 se-independent apoptosis) and staurosporine (STS, a protein kinase inhibitor)-induced apoptosis.
205 uce the concept of spatio-temporal steering (STS), which reduces, in special cases, to Einstein-Podol
206  regions across the (right) mid-anterior STG/STS (speakers) and bilateral mid-posterior STG/STS (vowe
207 S (speakers) and bilateral mid-posterior STG/STS (vowels), as well as the superior temporal plane inc
208 g tunneling microscopy and spectroscopy (STM/STS), photoemission electron microscopy/spectroscopy (PE
209              In this study, skin tape strip (STS) samples were collected from nonlesional skin of 62
210  lower bank of the superior temporal sulcus (STS) and neighboring regions of IT cortex.
211 high activation of superior temporal sulcus (STS) comparable to SC-Fathers, and functional connectivi
212 ivation of the mid-superior temporal sulcus (STS) cortical region identified by fMRI caused similar n
213 monkeys to map the superior temporal sulcus (STS) for BOLD modulation associated with visually guided
214 l pathway from the superior temporal sulcus (STS) projecting into dorsal subregions of the amygdala,
215 egion in the right superior temporal sulcus (STS) that lies within the auditory cortex, and is activa
216 ral regions of the superior temporal sulcus (STS) whose responses varied with segment length.
217 ry in the anterior superior temporal sulcus (STS), happy > angry in the superior temporal gyrus and p
218 erior and anterior superior temporal sulcus (STS), the extrastriate body area (EBA) and the occipital
219 ive patches of the superior temporal sulcus (STS), we found a double dissociation of areas processing
220 ve areas, into the superior temporal sulcus (STS).
221 x; voice-selective superior temporal sulcus (STS); the amygdala, which is crucial for processing of a
222 ified in the discovery of steroid sulfatase (STS) inhibiting lanostane triterpenes (LTTs) from a comp
223  blocked by aromatase and steroid sulfatase (STS) inhibitors confirming intracrine synthesis to estro
224                           Steroid sulfatase (STS) is a key enzyme involved in the biosynthesis of est
225 e-dependent cancer target steroid sulfatase (STS).
226 ss of adjunct sodium tanshinone IIA sulfate (STS) therapy on circulating inflammation markers in CAD
227 for Mechanical Assisted Circulatory Support (STS-INTERMACS) database were included.
228                Structured telephone support (STS) interventions reduced HF-specific readmission (high
229 d according to Society of Thoracic Surgeons (STS) criteria as any confirmed neurological deficit of a
230      Using the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (GTSD), we conduc
231 e obtained and Society of Thoracic Surgeons (STS) score was calculated.
232 orded, and the Society of Thoracic Surgeons (STS) score was calculated.
233 .1%) men; mean Society of Thoracic Surgeons (STS) score, 11.4% (4.0%); and mean LVSVI, 27.6 (5.0) mL/
234 iography data, Society of Thoracic Surgeons (STS) scores, and death were recorded in 737 patients (me
235            The Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter
236 6 sites in the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter
237 nrolled in the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter
238 nrolled in the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) TVT (Transcath
239            The Society of Thoracic Surgeons (STS)/American College of Cardiology Transcatheter Valve
240 n in PDAC patients with short-term survival (STS) and long-term survival (LTS).
241       As many of the sesquiterpene synthase (STS) genes encountered in nature are of plant origin and
242                      Sesterterpene synthase (STS)-mediated cyclization of the linear C25 isoprenoid p
243 INOSE SYNTHASE (RS), and STACHYOSE SYNTHASE (STS) are the enzymes responsible for RFO biosynthesis in
244 e ammonia-lyase (PAL) and stilbene synthase (STS) genes, followed by a rapid accumulation of E-resver
245 scaffold-generating sesterterpene synthases (STSs).
246 es for the 15-d Space Transportation System (STS)-131, 13-d STS-135, and 30-d Bion-M1 missions.
247  other metabolites in the sieve tube system (STS) at specific sites along the pathway.
248                                          The STS programme annually deploys a grid of 60,000-100,000
249                                          The STS reconciles all major theories about trade-offs betwe
250                                          The STS trap data have also created a unique opportunity to
251                                          The STS-ACC TVT Registry (Society of Thoracic Surgeons-Ameri
252  this regard, at various locations along the STS we could map metabolites and their related enzymes t
253 ulfate in ovariectomized mice by 69% and the STS activity in the liver by 81%.
254 s trended downward in US TAVR trials and the STS/American College of Cardiology Transcatheter Valve T
255 o measures of this effect referred to as the STS weight and robustness.
256 us friction, previous studies considered the STS as the primary place of energy dissipation in the co
257                                Mice from the STS-131 mission exhibited reduced myogenic (Myf5 and -6)
258                                Data from the STS/ACC TVT Registry have been used to develop a predict
259                 The power dissipation in the STS because of the presence IHC stereocilia increased as
260            The face-selective patches in the STS fundus were most sensitive to facial expression, as
261                            Three SNPs in the STS gene (rs6639786, rs2270112, and rs17268988) and one
262 we investigated the power dissipation in the STS.
263  bundle reduced the power dissipation in the STS.
264 ergoing TAVR in centers participating in the STS/ACC TVT Registry from November 1, 2011, to February
265 ia bundle--the IHC stereocilia increased the STS power dissipation by 50- to 100-fold.
266 maps within and around the lower bank of the STS and extend these prior findings to scene-selective c
267  Registry has been a joint initiative of the STS and the ACC in concert with multiple stakeholders.
268 discussed with regard to the function of the STS as a unique and highly complex metabolic space withi
269 itions, consistent with the operation of the STS as a unique symplasmic domain.
270 the relationships among polymorphisms of the STS gene and SULT2A1 gene, dehydroepiandrosterone (DHEA)
271                    During quiet stand of the STS test, compared to baseline, heart rate was 50% highe
272 ace patch in the anterior fundus (AF) of the STS while macaques freely view complex videos rich with
273 riction between the two flat surfaces of the STS.
274 uropil volume in the rodent homologue of the STS.
275            When examined parametrically, the STS response increased with segment length up to approxi
276                       Deletions spanning the STS (steroid sulfatase) gene at Xp22.31 are associated w
277 S) with fMRI to test the prediction that the STS and amygdala are functionally connected during face
278               Studies demonstrating that the STS computes the actions of moving faces and bodies (e.g
279                      Addition of RVSP to the STS score significantly reclassified the risk for longer
280 e found the C allele of rs2270112 within the STS gene to be over-transmitted in males with ADHD.
281              Several visual areas within the STS of the macaque brain respond strongly to faces and o
282 ace-selective patches segregating within the STS.
283 long the source-sink pathway and between the STSs of these three cucurbits.
284 re at increased surgical risk based on their STS PROM score and other risk factors.
285 e of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) Registry.
286 at on the basis of standard medical therapy, STS further reduce elevated hs-CRP and other circulating
287                        We suggest that these STS measures enable a new way to assess nonclassical cor
288 tum chemical calculations suggest that these STSs catalyze an unusual cyclization path involving repr
289 tion of predicted METs and resting LV-GLS to STS, resting RVSP, left ventricular end-systolic dimensi
290 ological pathogenesis of ADHD with regard to STS polymorphisms and neurosteroid levels.
291 ients with FA to peanut, suggesting a unique STS proteomic endotype for AD FA+ that persists into adu
292 rdiac surgery public reporting program using STS clinical registry data and National Quality Forum-en
293     In contrast, we found that ventrolateral STS is driven preferentially during versional movements.
294 5 patients with histopathologically verified STS were prospectively enrolled for an integrated (18)F-
295 After we reported EO-33 as a potent in vitro STS inhibitor without undesirable estrogenic activity an
296 ], respectively; P > .99) and congruent with STS predicted risk of mortality.
297 that of doxorubicin in elderly patients with STS and offers superior tolerability for hematologic tox
298 vorably with SAVR in high-risk patients with STS PROM scores traditionally considered intermediate ri
299  years) were included if they presented with STS diagnosed between 2008 and 2015, had a baseline cont
300  Our results show that multiple areas within STS modulate during all movement types studied, includin

 
Page Top